Fingerprint
Dive into the research topics of 'Phase ii trial of upfront bevacizumab, irinotecan, and temozolomide for unresectable glioblastoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase ii trial of upfront bevacizumab, irinotecan, and temozolomide for unresectable glioblastoma
Katherine B. Peters, Emil Lou, Annick Desjardins, David A. Reardon, Eric S. Lipp, Elizabeth Miller, James E. Herndon, Frances McSherry, Henry S. Friedman, James J. Vredenburgh
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations